34. 神経線維腫症 Neurofibromatosis Clinical trials / Disease details

臨床試験数 : 133 / 薬物数 : 186 - (DrugBank : 67) / 標的遺伝子数 : 79 - 標的パスウェイ数 : 190

3 trials found

diseases per page:

Showing 1 to 3 of 3 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00076102 (ClinicalTrials.gov)	July 21, 2004	13/1/2004	Pirfenidonein Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neur ...	Phase II Trial of Pirfenidonein Children, Adolescents, and Young Adults With Neurofibromatosis Type ...	Neurofibromatosis 1;Neurofibroma, Plexiform	Drug: Pirfenidone	National Cancer Institute (NCI)	NULL	Completed	3 Years	21 Years	All	36	Phase 2	United States
2	NCT00053937 (ClinicalTrials.gov)	December 2002	5/2/2003	Pirfenidone in Treating Young Patients With Neurofibromatosis Type 1 and Plexiform Neurofibromas	Phase I Trial Of Pirfenidone In Children With Neurofibromatosis Type 1 And Plexiform Neurofibromas	Neurofibromatosis Type 1;Precancerous Condition	Drug: pirfenidone	National Cancer Institute (NCI)	NULL	Completed	3 Years	21 Years	Both		Phase 1	United States
3	NCT00754780 (ClinicalTrials.gov)	September 2000	16/9/2008	Clinical Trial of Pirfenidone in Adult Patients With Neurofibromatosis 1	Phase II Clinical Trial of Pirfenidone for the Treatment of Patients With Neurofibromatosis Type I	Neurofibromatosis	Drug: Pirfenidone	Mayo Clinic	NULL	Completed	18 Years	70 Years	Both	24	Phase 2	NULL

First Previous1Next Last